{"3963": "when not all exacerbation events occurred during the viral infection", "3855": "viral infection increases airway inflammation which aggravates disease symptoms", "3856": "Recent advances in in vitro air-liquid interface 3D cultures, organoid cultures and the use of novel human and animal challenge models", "3854": "Respiratory virus infection", "3857": "compiling and collating the current known mechanisms of viral-induced exacerbation of chronic airway inflammatory diseases", "3858": "prevalence of different respiratory viral infections in causing exacerbations in chronic airway inflammatory diseases", "3859": "These classical mechanisms of viral induced acute exacerbations", "3860": "recent data regarding viral interactions with the airway epithelium that could also contribute to, or further aggravate, acute exacerbations of chronic airway inflammatory diseases.", "3861": "the understanding of viral induced exacerbation in chronic airway inflammatory diseases", "3862": "airway inflammation leading to complications", "3863": "both the upper airway (such as chronic rhinosinusitis, CRS) and lower airway", "3864": "complexity and heterogeneity of the disease", "3865": "increased susceptibility of chronic airway inflammatory disease patients toward viral respiratory infections", "3866": "interplay between virus and pathogenic bacteria in exacerbating chronic airway inflammatory diseases", "3867": "morbidity and sometimes mortality in patients", "3869": "interplay between virus and pathogenic bacteria in exacerbating chronic airway inflammatory diseases", "3870": "infiltration of activated immune cells", "3871": "viral infection", "3872": "equally high, having been detected in 30-80% of acute COPD exacerbations", "3873": "ease of transmission and infection", "3874": "disruption of tight junctions with the resulting increased rate of viral infiltration", "3875": "to properly manage exacerbations via supplementary treatments that may alleviate the exacerbation symptoms or prevent severe exacerbations", "3876": "dysregulated inflammation in most chronic airway inflammatory diseases", "3877": "upper airway", "3878": "compiling and collating the current known mechanisms of viral-induced exacerbation of chronic airway inflammatory diseases", "3879": "Respiratory Viral Infections in Exacerbation of Chronic Airway Inflammatory Diseases: Novel Mechanisms and Insights From the Upper Airway Epithelium\n\nhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052386/\n\nSHA: 45a566c71056ba4faab425b4f7e9edee6320e4a4\n", "3880": "bacterial infections", "3881": "more viruses were recovered during acute exacerbations events", "3882": "Rhinovirus (RV) and respiratory syncytial virus (RSV)", "3883": "parainfluenza virus (PIV), influenza virus (IFV) and adenovirus (AdV)", "3884": "bocavirus (BoV), human metapneumovirus (HMPV), certain coronavirus (CoV) strains, a specific enterovirus (EV) strain EV-D68, human cytomegalovirus (hCMV) and herpes simplex virus (HSV)", "3885": "they can infect both the upper and/or lower airway", "3886": "airway epithelial cells", "3887": "the cells release antiviral factors and cytokines that alter local airway inflammation and airway niche", "3888": "type 1 inflammatory responses", "3891": "impaired or aberrant", "3892": "compiling and collating the current known mechanisms of viral-induced exacerbation of chronic airway inflammatory diseases", "3893": "to provide further understanding of viral induced exacerbation to identify potential pathways and pathogenesis mechanisms that may be targeted as supplementary care for management and prevention of exacerbation", "3894": "due to the current scarcity of antiviral drugs for the management of viral-induced exacerbations", "3941": "cell death and injury to the epithelial barrier will also induce the expression of IL-25, IL-33 and TSLP", "3942": "release type I (IFN\u03b1/\u03b2) and type III (IFN\u03bb) interferons, cytokines and chemokines", "3943": "viral exacerbation in chronic airway inflammatory diseases.", "3944": "heighten local inflammation and the infiltration of granulocytes, T-cells and B-cells", "3945": "viral infections such as RV and RSV promote a Type 2-biased immune response", "3946": "worsens the classical symptoms of disease and may further lead to life-threatening conditions due to breathing difficulties", "3947": "exacerbating COPD, CRSsNP and even CRSwNP in certain cases", "3948": "IL-25, IL-33 and TSLP", "3949": "ILC2s are a group of lymphoid cells", "3950": "massive damage", "3951": "work in concert to activate ILC2s to further secrete type 2 cytokines IL-4, IL-5, and IL-13 which further aggravate the type 2 inflammation in the airway causing acute exacerbation", "3952": "increased ILC2 activation, which retain the capability of differentiating to ILC1, may also further augment the neutrophilic response and further aggravate the exacerbation", "3954": "do not activate an ILC2 response", "3960": "antiviral state will be activated to clear the invading pathogen from the airway", "3961": "worsens the symptoms of airway diseases", "3962": "increased susceptibility of chronic airway inflammatory disease patients toward viral respiratory infections", "3964": "the nasal epithelium remains the primary site of most infections", "3965": "more complex interplay between the virus and upper airway epithelium which synergize with the local airway environment in line with the \"united airway\" hypothesis", "3966": "exacerbation of their symptoms", "3967": "worsens the symptoms", "3968": "to determine the contribution of the microbiome and mycobiome to viral infections", "3969": "recent data regarding viral interactions with the airway epithelium that could also contribute to, or further aggravate, acute exacerbations of chronic airway inflammatory diseases", "3970": "Patients with chronic airway inflammatory diseases", "3971": "type 2-skewed inflammatory response which deprives the airway", "3972": "weak type 1 inflammation-inducing viruses", "3973": "Other than these direct evidence of miRNA changes in contributing to exacerbations, an increased number of miRNAs and other non-coding RNAs responsible for immune modulation are found to be altered following viral infections", "3974": "prolong airway inflammation", "3975": "heighten local inflammation and the infiltration of granulocytes, T-cells and B-cells", "3976": "human papilloma virus (HPV),", "3977": "HPV infection in causing chronic inflammation in the airway and their association to exacerbations of chronic airway inflammatory diseases", "3978": "continuous expression of antiviral genes", "3979": "cause the virus to linger longer in the airway due to the lack of antiviral clearance", "3980": "acute exacerbation", "3981": "IFV (Yan et al., 2016; Guibas et al., 2018) and certain CoV (including the recently emerged COVID-19 virus) (Tao et al., 2013; Yue et al., 2018; Zhu et al., 2020)", "3982": "massive damage and cell death to the epithelial barrier", "3983": "further compounds the cell deaths in IFV infected epithelium", "3984": "further contact with other pathogens and allergens in the airway which may then prolong exacerbations or results in new exacerbations", "3985": "promote further epithelial remodeling during its regeneration", "3986": "receive their annual influenza vaccination", "3987": "induction of vasodilation or tight junction opening factors", "3988": "disruption of tight junctions with the resulting increased rate of viral infiltration", "3989": "weak type 1 inflammation-inducing viruses such as RV and RSV (Kling et al., 2005; Wood et al., 2011; Ravi et al., 2019)", "3990": "angiopoietin-like 4 (ANGPTL4) and bactericidal/permeabilityincreasing fold-containing family member A1 (BPIFA1)", "3991": "relationship between asthma and COPD exacerbations", "3992": "specific bacterial species in the microbiome which may thrive in the inflamed airway environment", "3993": "the effect induced by the virus may destabilize the equilibrium of the microbiome present", "3994": "ciliary gene expression", "3995": "impaired bacterial immune response", "3996": "more far reaching effect", "3997": "due to the interplay between virus and pathogenic bacteria in exacerbating chronic airway inflammatory diseases", "3998": "microbiome-based therapies are in their infancy but have shown efficacy in the treatments of irritable bowel syndrome by restoring the intestinal microbiome", "3999": "increase neutrophilic activation", "4000": "upper airway epithelium", "4001": "serves to increase contact between environmental triggers with the lower airway and resident immune cells", "4002": "oxidative stress", "4003": "modulation of miRNAs and epigenetic modification such as DNA methylation and histone modifications", "4004": "growth of pathogenic bacteria that may replace the airway microbiome", "4005": "inflammation and alteration of the lower airway environment, resulting in prolong exacerbation episodes following viral infection", "4006": "RV, RSV, and IFV", "4007": "directly destroy the cilia of the ciliated cells", "4008": "disrupt the equilibrium of the mucociliary function following viral infection, resulting in symptoms of acute exacerbation", "4009": "more foreign material and allergen to enter the airway", "4010": "short non-coding RNAs involved in post-transcriptional modulation of biological processes, and implicated in a number of diseases", "4011": "viral infections", "4012": "circulating miRNA changes", "4013": "infected epithelium and responding immune cells", "4014": "increase miR-21 and augmented inflammation in experimental murine asthma models", "4015": "induce oncostatin M (OSM) which causes tight junction opening", "4016": "miR-22 was shown to be suppressed", "4017": "targets to modulate viral induced airway changes", "4018": "epigenetic modification such as DNA methylation", "4019": "association of epigenetic modification and chronic airway inflammatory diseases", "4020": "antiviral factors such as IFN\u03b3 epigenetically modifies the viral resistance of epithelial cells", "4021": "antiviral factors such as IFN\u03b3 epigenetically modifies the viral resistance of epithelial cells", "4022": "altered inflammatory state contributing to further viral persistence and exacerbation of chronic airway inflammatory diseases", "4023": "enhanced production of reactive oxygen species (ROS),", "4024": "The airway epithelium of patients with chronic airway inflammatory diseases are usually under a state of constant oxidative stress", "4025": "trigger the further production of ROS as an antiviral", "4026": "infiltrating cells in response to the infection such as neutrophils will also trigger respiratory burst as a means of increasing the ROS in the infected region", "4027": "increases airway inflammation", "4028": "important information regarding viral pathogenesis and changes induced within the airway of chronic airway inflammatory disease patients to identify novel targets and pathway for improved management of the disease", "4029": "epithelial cell models such as the air-liquid interface, in vitro airway epithelial model that has been adapted to studying viral infection and the changes it induced in the airway", "4030": "to identify systemic mechanisms of acute exacerbation", "4031": "humanized mouse model that possess human immune cells", "4032": "best mode of verification of the associations of the virus with the proposed mechanism of viral induced acute exacerbations", "3868": "complex interactions between the host and the exacerbation agents", "3687": "long non-coding RNAs (lncRNAs)", "3688": "to calculate the relevance between lncRNA and protein in a heterogeneous network", "3689": "protein-protein interaction (PPI)", "3690": "over-expressed in many human oncogenic tissues and regulates cell cycle and survival 31", "941": "Western blot analysis", "933": "mosquitoes and that is naturally present in rodent reservoirs", "934": "acute and fatal encephalitis", "935": "35%", "936": "10%", "937": "Dengue virus", "938": "differential alterations in VEEV-infected astrocytes", "939": "endoplasmic reticulum (ER) stress due to protein misfolding", "940": "inositolrequiring enzyme 1 (IRE1), protein kinase RNA-like ER kinase (PERK), and activating transcription factor 6 (ATF6) (33, 34)", "942": "cluster 20", "943": "a transcription factor that can be induced by numerous signals", "557": "2012", "558": "21%", "559": "e odds of infection among males were found to be twice as high as that of females", "560": "Dromedary camels", "562": "11-13 days", "563": "16 days", "564": "supportive and symptomatic", "565": "between 41 and 60 years", "279": "pyrin domain-containing 3", "280": "the downstream molecule, caspase-1,", "281": "SARS-CoV 3a protein", "282": "transmembrane pore-forming viral proteins", "283": "Betacoronavirus", "284": "Coronaviridae", "285": "an enveloped virus with a single-stranded positive-sense RNA genome of approximately 30 kb in length", "287": "single-stranded", "288": "8,098", "289": "9.6%,", "290": "tumor necrosis factor (TNF)-\u03b1, interleukin (IL)-1\u03b2, and IL-6", "292": "by sensing the cellular damage or distress induced by viroporins", "293": "76", "294": "Ca 2+ -permeable", "296": "NLRP3 inflammasome", "257": "7.3 billion", "248": "Middle East respiratory syndrome coronavirus", "249": "Transmissibility and severity", "250": "January 30, 2020", "251": "H7N9", "252": "a series of modeling articles", "253": "20% to 30%", "254": "20%", "255": "less than 1", "1657": "35\u202f000 to 60\u202f000", "1635": "expression of adjacent genes", "3258": "Nuclear receptors (NRs)", "3259": "a class of ligand-inducible transcription factors", "3260": "homeostasis, differentiation, embryonic development, and organ physiology", "3261": "seven", "3262": "a reliable 3D (three dimensional) structure of the target protein", "3263": "X-ray crystallography", "3264": "time-consuming and expensive", "3265": "membrane proteins", "3266": "KEGG (Kyoto Encyclopedia of Genes and Genomes) [71] at http://www.kegg.jp/kegg/.", "546": "hemorrhagic fever with renal syndrome", "547": "enveloped, negative-sense RNA virus", "548": "Hantavirus", "549": "plasma viral load", "551": "an antiviral medicine", "552": "IFITM3 SNP rs12252 C allele and CC genotype", "554": "IFITM1, 2, and 3", "555": "restriction of viral entry into cells", "556": "rs12252 C allele", "2754": "RP transmission model", "2755": "Reservoir-People (RP) transmission network model", "2756": "2.30 from reservoir to person and 3.58 from person to person", "2757": "Our model showed that the transmissibility of SARS-CoV-2 was higher than the Middle East respiratory syndrome in the Middle East countries, similar to severe acute respiratory syndrome, but lower than MERS in the Republic of Korea.", "2758": "transmission from Huanan Seafood Wholesale Market (reservoir) to people,", "2759": "The bats were divided into four compartments: susceptible bats (S B ), exposed bats (E B ), infected bats (I B ), and removed bats (R B ).", "2760": "susceptible bats (S B ), exposed bats (E B ), infected bats (I B ), and removed bats (R B ).", "2761": "four", "2762": "the seafood market", "2763": "five compartments", "2764": "5.2 days", "2765": "5-day delay", "2766": "3 to 7 days", "2767": "5.8 days", "2768": "0.5 times that of symptomatic infection", "2769": "0.3 million", "2770": "2.87 million", "2771": "the expected number of secondary infections that result from introducing a single infected individual into an", "2772": "2.30", "2773": "0.8-1.3", "2774": "the R 0 was estimated based on limited data which published in a literature", "2775": "decrease R 0", "2776": "the transmissibility of SARS-CoV-2 was higher than the Middle East respiratory syndrome in the Middle East countries, similar to severe acute respiratory syndrome, but lower than MERS in the Republic of Korea.", "2777": "to provide a mathematical model for calculating the transmissibility of SARS-CoV-2", "5149": "grown in Dulbecco's modified Eagle's medium", "5150": "Old World (OW) and New World (NW", "5151": "viral hemorrhagic", "5152": "live attenuated", "5153": "lung epithelial cells are one of the initial cell targets of humans following inhalation of mammarenavirions", "5154": "1 day", "5155": "cardiac glycoside ouabain", "5156": "ATP1A1", "5157": "\nCombination therapy", "5158": "ATP1A1 and PHB contribute to efficient multiplication of mammarenaviruses using genetics and pharmacological inhibition of the genes", "5159": "using genetics and pharmacological inhibition of the genes", "5175": "mild skin infections to fatal necrotizing pneumonia", "5176": "8-30%", "5177": "tissue resident alveolar macrophages", "5178": "The subsequent infection with Gram-positive bacteria", "5179": "Reduced TNF\u03b1 production by NK cells", "5180": "a pneumococcal pore-forming toxin with low affinity to lung epithelial cells", "5181": "epithelial barrier damage, exaggerated innate immune response, and cytokine storm.", "568": "interferon-induced transmembrane", "569": "three", "570": "absence and presence of 2BP", "571": "IFITM5 with FKBP11", "572": "immune system activity in the osteoblast cells", "573": "S-palmitoylation on the protein", "574": "bonerestricted IFITM-like (BRIL) protein", "575": "the region upstream of the ifitm5 gene lacks the interferon regulatory elements", "576": "65% similarity", "577": "65% similarity),", "580": "aspartate-rich domain", "5256": "11 June 2009", "5257": "1/40", "5258": "conferring 50% protection against a viral challenge", "5259": "All experiments were performed in the presence of the same negative and positive controls, the latter including sera with 1/40, 1/80, 1/160 and 1/320 antibody titers.\n", "5260": "residual signature of the remote exposure of these individuals to H1N1 viruses circulating before 1957", "5261": "week 38", "3267": "11,399", "3268": "49.2%", "3269": "2.2%)", "3270": "2005", "3271": "cough, rhinitis, fever and other common clinical symptoms", "3272": "\u226414 years old", "3273": "1.94: 1", "4077": "to comprehensively investigate the epidemiology of adult viral RTIs using PCR/ESI-MS and compare the diagnostic performance between PCR/ESI-MS and conventional culture methods for identifying multiple, clinically relevant, respiratory viruses, including enterovirus and rhinovirus.", "4078": "1 (2.4%)", "4079": "4.1% of cases", "4080": "parainfluenza infection, old age, and immunosuppression", "4081": "multilocus polymerase chain reaction coupled with electrospray ionization mass spectrometry (PCR/ESI-MS)", "4082": "if the patients met one of the following conditions: corticosteroid treatment, solid organ or hematopoietic stem cell recipient, or chemotherapy for an underlying malignancy during the past 6 months", "4083": "9-month", "4084": "263", "4085": "rhinovirus", "917": "31 kb", "918": "single-stranded, linear, and nonsegmented RNA of around 31 kb.", "919": "30,847", "920": "20kb nucleotides", "921": "5= side of the genome", "502": "childhood tuberculosis", "504": "despite an increase in the global childhood population from 605 million in 2000 to 664 million in 2015", "507": "81%", "510": "increase in the global childhood population from 605 million in 2000 to 664 million in 2015", "511": "664 million", "512": "25%", "513": "1.3 times in highincome countries", "514": "81%", "515": "\n", "516": "contribute to substantial morbidity across the life course", "517": "The risk of developing at least one of the major sequelae was estimated as 6% after an ambulatory pneumonia event and 14% after an episode of hospitalized pneumonia", "518": "point-of-care lung ultrasound", "520": "Widespread use of pneumococcal conjugate vaccination and Haemophilus influenzae type B conjugate vaccination", "521": "37%", "522": "presumed bacterial pneumonia", "524": "pneumonia cases with WHO-defined alveolar consolidation, as well as those with other abnormal chest radiograph infiltrates and a serum C-reactive protein of at least 40 mg/L", "530": "pneumococcal conjugate vaccination-7 introduction", "532": "by 50% in children younger than 5 years", "533": "chest", "534": "S. pneumoniae and H. influenzae type B", "535": "infants might therefore be born with low transplacental anti-pertussis immunoglobulin G levels", "536": "major cause of morbidity and mortality", "537": "low birth weight, which is associated with 3.2 times increased odds of severe pneumonia in low-and middle-income countries, and 1.8 times increased odds in high-income countries", "538": "increases odds of pneumonia by 1.6 times", "539": "HIV infection", "540": "68%.", "541": "Influenza vaccination during pregnancy is safe, provides reasonable maternal protection against influenza, and also protects infants for a limited period from confirmed influenza infection", "923": "a rare complication of pneumonia", "4573": "dense or fluffy opacity that occupies a portion or whole of a lobe, or the entire lung", "5163": "accumulation of point mutations", "5164": "a positive-sense single stranded RNA enveloped virus causing chronic hepatitis in most untreated patients (about 80%), with the consequent risk of developing cirrhosis and hepatocellular carcinoma.", "5165": "about 3,000 aminoacids", "5166": "NS1 and NS2", "5167": "its high mutation rate that gives rise to highly diversified viral variants", "5168": "envelope glycoproteins E1 and E2", "5169": "based on antigenic differences of their nucleoprotein and matrix protein", "5170": "influenza A", "2477": "severe joint pain", "2471": "fever disease, headache, rash, nausea, vomiting, myalgia, and arthralgia", "2470": "arthropod-borne virus (arbovirus)", "2472": "Currently, there is no vaccine or antiviral treatment", "2473": "finally nominates a possible vaccine approach against CHIKV infection.", "2474": "arthropod-borne virus (arbovirus)", "2475": "an arthropod-borne virus (arbovirus)", "2476": "Aedes aegypti", "2478": "Kimakonde", "2479": "that which contorts or bends up", "2480": "the illness of the bended walker", "2481": "a sylvatic cycle", "2482": "Ae. aegypti and Ae. albopictus", "2483": "in an urban cycle whereby the mosquito spreads the disease from an infected human to an uninfected human", "2484": "The 2005-2006 epidemic of CHIKV in La Reunion islands in the Indian Ocean", "2485": "over 46,000", "2486": "the epidemiology and global expansion of CHIKV", "2487": "5.3-5.8 log 10 PFU", "2488": "three", "2489": "gene sequences of an Envelope protein (E1),", "2490": "Using phylogenetic models, Cherian et al. estimate that the Asian", "2491": "between 100 and 840 y ago", "2492": "CHIKV has come a long way, with several mutations incorporated, and has continued to wreak epidemics in several regions.", "2493": "Indian epidemic in 2005-2006, which was followed by a sudden explosion of cases in 2007", "2494": "Kerala isolate", "2495": "1", "2496": "4-7 d", "2497": "The first stage is acute, while the second stage, experienced by most but not all, is persistent, causing disabling polyarthritis.", "2498": "makes its genome susceptible to mutations", "2499": "40%", "2500": "polyarthralgia", "2501": "congenital illness and fetal death", "2502": "high number of nociceptive nerve endings found within the joints and muscle connective tissues", "2503": "More than 50%", "2504": "more than 33%", "2505": "children", "2506": "respiratory failure, cardiovascular decompensation, meningoencephalitis, severe acute hepatitis, severe cutaneous effects, other central nervous system problems, and kidney failure", "2507": "makes its genome susceptible to mutations", "2508": "CHIKV with an alanine in the 226 position of the E1 gene", "2509": "an ecological pressure", "2510": "CHIKV's secondary vector species, Ae. albopictus, to supplement Ae. aegypti as its primary vector", "2511": "Ae. albopictus", "2512": "34%", "2513": "Madagascar", "2514": "Ae. albopictus became the main vector for CHIKV within 1-2 y after CHIKV was introduced to the region [", "2515": "increase in infectivity of Ae. albopictus", "2516": "Ae. albopictus", "2517": "100 times more infective to Ae. albopictus than it was to Ae. aegypti", "2518": "Ae. albopictus", "2519": "over 300 y", "2520": "Ae. albopictus is common in urban areas", "2521": "50%", "2522": "congenital illness and fetal death", "2523": "it is associated with a high degree of morbidity", "2524": "motherto-child transmission most likely happens transplacentally shortly before delivery", "2525": "nineteen cases of neonatal infection associated with intrapartum maternal viremia that progressed to develop encephalitis owing to vertical transmission from infected mothers", "2526": "RANTES levels were significantly suppressed in severe CHIKF patients", "2527": "RANTES levels were significantly suppressed in severe CHIKF patients", "2528": "Category C pathogen", "2529": "DNA-based vaccines can be produced more rapidly than protein-based vaccines.", "4221": "Wuhan, Hubei Province, China", "328": "Frequent and severe", "329": "bronchitis, pneumonia and pleurisy", "330": "NK cells", "331": "Excessive reactive oxygen species", "332": "ROS"}